Amgen (AMGN) Tax Provisions (2009 - 2026)

Amgen has reported Tax Provisions for 18 years, with the latest figure at $265.0 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions rose 9.05% year-over-year to $265.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 79.5% YoY), and the FY2025 full-year result was $1.3 billion, up 143.74% from the prior year.
• Tax Provisions for Q1 2026 stood at $265.0 million, up from $181.0 million in the prior quarter.
• The five-year high for Tax Provisions was $705.0 million in Q3 2025, with the low at $45.0 million in Q1 2024.
• Average Tax Provisions over 5 years is $234.2 million, with a median of $214.0 million recorded in 2022.
• Year-over-year, Tax Provisions tumbled 92.51% in 2024 and soared 440.0% in 2025.
• Tracing AMGN's Tax Provisions over 5 years: stood at $132.0 million in 2022, then tumbled by 35.61% to $85.0 million in 2023, then jumped by 82.35% to $155.0 million in 2024, then advanced by 16.77% to $181.0 million in 2025, then soared by 46.41% to $265.0 million in 2026.
• The last three Tax Provisions figures came in at $265.0 million (Q1 2026), $181.0 million (Q4 2025), and $705.0 million (Q3 2025), per Business Quant data.

Peer Comparison